Your browser doesn't support javascript.
loading
Medicinal cannabis use among young adults during California's transition from legalized medical use to adult-use: a longitudinal analysis.
Ataiants, Janna; Wong, Carolyn F; Odejimi, Omolola A; Fedorova, Ekaterina V; Conn, Bridgid M; Lankenau, Stephen E.
Afiliación
  • Ataiants J; Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA.
  • Wong CF; Division of Adolescent and Young Adult Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Odejimi OA; Keck School of Medicine, Department of Pediatrics, University of Southern California, Los Angeles, CA, USA.
  • Fedorova EV; Department of Educational Psychology, Leadership and Higher Education, College of Education, University of Nevada Las Vegas, Las Vegas, NV, USA.
  • Conn BM; Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA.
  • Lankenau SE; Division of Adolescent and Young Adult Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Am J Drug Alcohol Abuse ; 50(2): 229-241, 2024 Mar 03.
Article en En | MEDLINE | ID: mdl-38407837
ABSTRACT

Background:

In 2016, California transitioned from legalized medical cannabis use to adult-use. Little is known about how this policy change affected medicinal cannabis use among young adults.

Objectives:

To identify longitudinal groups of medicinal cannabis users and concurrent changes in health- and cannabis use-related characteristics among young adults in Los Angeles between 2014 and 2021.

Methods:

Cannabis users (210 patients and 156 non-patients; 34% female; ages 18-26 at baseline) were surveyed annually across six waves. Longitudinal latent class analysis derived groups from two factors - cannabis patient status and self-reported medicinal use. Trajectories of health symptoms, cannabis use motives, and cannabis use (daily/near daily use, concentrate use, and problematic use) were estimated across groups.

Results:

Three longitudinal latent classes emerged Recreational Users (39.3%) - low self-reported medicinal use and low-to-decreasing patient status; Recreational Patients (40.4%) - low self-reported medicinal use and high-to-decreasing patient status; Medicinal Patients (20.3%) - high self-reported medicinal use and high-to-decreasing patient status. At baseline, Medicinal Patients had higher levels of physical health symptoms and motives than recreational groups (p < .05); both patient groups reported higher level of daily/near daily and concentrate use (p < .01). Over time, mental health symptoms increased in recreational groups (p < .05) and problematic cannabis use increased among Recreational Patients (p < .01).

Conclusions:

During the transition to legalized adult-use, patterns of medicinal cannabis use varied among young adults. Clinicians should monitor increases in mental health symptoms and cannabis-related problems among young adults who report recreational - but not medicinal - cannabis use.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Marihuana Medicinal Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Am J Drug Alcohol Abuse Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Marihuana Medicinal Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Am J Drug Alcohol Abuse Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...